Rhinomed (ASX:RNO) Price-to-Tangible-Book : (As of May. 23, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Price-to-Tangible-Book?

As of today (2024-05-23), Rhinomed's share price is A$0.04. Rhinomed's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was A$-0.02. Hence, Rhinomed's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Rhinomed's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Rhinomed's highest Price to Tangible Book Ratio was 18.62. The lowest was 2.14. And the median was 10.28.

ASX:RNO's Price-to-Tangible-Book is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 2.69
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Rhinomed's share price is A$0.04. Rhinomed's Book Value per Sharefor the quarter that ended in Jun. 2023 was A$-0.02. Hence, Rhinomed's P/B Ratio of today is .

Rhinomed Price-to-Tangible-Book Historical Data

The historical data trend for Rhinomed's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed Price-to-Tangible-Book Chart

Rhinomed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

18.62

2.14

15.40

10.45

Rhinomed Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial															15.40	61.58	10.45	-	-

Competitive Comparison of Rhinomed's Price-to-Tangible-Book

For the Medical Devices subindustry, Rhinomed's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhinomed's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rhinomed's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Rhinomed's Price-to-Tangible-Book falls into.

Rhinomed Price-to-Tangible-Book Calculation

Rhinomed's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	0.04	/	-0.022
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Rhinomed Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Rhinomed's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhinomed (ASX:RNO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

RHNMF:USA

Address

132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121

Website

https://www.rhinomed.global

Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines